Previous Page  15 / 55 Next Page
Information
Show Menu
Previous Page 15 / 55 Next Page
Page Background

F

ive months after the FDA’s deeming

regulations were released, there are still

a lot of questions and much confusion

around what they mean for retailers.

Following up on our last issue, which offered a

regulatory overview by Tom Briant, executive

director of the National Association of Tobacco

Outlets,

TBI

took a more detailed look at what

the regulatory changes under way mean for the

retail landscape. Here’s what we found out.

First, the good news: As concerning as the

deeming regulations are, they could have been a

whole lot worse. For example, while many remain

concerned about what the requirements will ul-

timately mean for flavored tobacco, there is cur-

rently nothing in the regulations that prohibits

flavors in any of the newly regulated categories—

cigars, pipe tobacco, e-liquids and hookah prod-

ucts. “The only flavored products banned remain

flavored cigarettes, with the exception of men-

thol,” notes Briant.

Furthermore, self-service display of those newly

regulated products is also still permitted, as long as

no state or local law prohibiting them is in effect, in

which case such bans will remain in effect.Also, ac-

cessories do not fall under the FDA’s purview. FDA

regulatory authority now covers premium and do-

mestic cigars, e-cigarettes and all vapor products,

hookah tobacco, dissolvable nicotine products and

gels, but matches, lighters, humidors, cigar cutters,

ashtrays, hookah tongs and pipe tobacco pouches

are not regulated.

“However, ‘components’ and ‘parts’ as defined

by FDA are regulated,” cautions Briant. “That

means traditional tobacco pipes and, in the case

of vapor products, e-liquids and parts of the ap-

paratus, such as the cartridge or tank, batteries

and digital displays on tank models.”

What’s more, while the deeming regulations

do ban free samples, there is no provision against

buy-one-get-one-free promotions, nor does the

sampling ban prevent retailers from rewarding

regular customers through loyalty programs. (See

“Sizing up the Sampling Ban” sidebar, at right).

“Also, products that have been introduced and

are in the marketplace prior to August 8 will

be able to remain in market for a limited time

provided that their manufacturers file the neces-

sary applications to seek FDA approval for those

products,” adds Briant. In other words, it will be

status quo for stores shelves in the near term.

What is a free sample?

The FDA defines a free sample as a tobacco

product that does not cost the recipient any-

thing. In other words, no money changes hands

between the customer and the retailer.

Are promotions like buy two,

get one free or buy one, get one free banned?

The answer is no. That is because there is an

exchange of money between the customer

and the retailer in this type of promotion, so

the free product is not really free. Also, FDA

does not have the authority to regulate to-

bacco prices, and if the agency were to ban

those types of promotions that would be a

price regulation. Pricing is up to Congress, not

FDA. Finally, in 2012 a U.S. Court of Appeals

court made a ruling to address this issue and

they decided that while free samples can be

banned when no money exchanged hands,

promotional prices do not constitute free

samples and are to be allowed.

Are coupons banned?

Yes and no. If the coupon is for a free tobacco

product with no money exchanging hands, the

coupon is not allowed. However, if the coupon

is $1 off of the price of a product and the price

is more than $1, then the coupons are allowed

because there is still an exchange of money

between the customer and the retailer.

Are free products under loyalty

or award programs banned?

No, the U.S. court decision referred to above

found that loyalty programs are provided to

adults only and there is a prior exchange of

money to earn points or awards to apply to-

ward the free product at a later date thus mak-

ing the product not really free.

1.

2.

3.

4.

Sizing Up the Sampling Ban

NATO’s Tom Briant offers these answers to the most frequently

asked questions about the FDA ban on free samples.

30

TOBACCO BUSINESS INTERNATIONAL

SEPTEMBER/OCTOBER 2016